Papers
4
Total Citations
31
H-Index
4
About
Dr. Anton F. Engelsman is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for complex endocrine and neuroendocrine tumors. His major contributions center on the safety and efficacy of robotic and laparoscopic surgery for rare conditions, particularly pheochromocytoma and small bowel neuroendocrine neoplasms (SB-NEN). In a landmark 2024 international multicenter study (12 citations), Dr. Engelsman demonstrated that robotic and laparoscopic adrenalectomy for pheochromocytoma is both feasible and safe, establishing a new standard of care. His 2021 international survey (8 citations) revealed critical barriers to adopting minimally invasive surgery for SB-NEN, guiding future implementation strategies. Dr. Engelsman also investigates surgical outcomes in special populations, as shown in his 2024 analysis of adrenalectomy for pheochromocytoma in patients with obesity (7 citations). Notably, his 2020 case report on robotic enucleation of an intra-pancreatic insulinoma (4 citations) showcases his technical innovation in parenchyma-sparing pancreatic surgery, preserving endocrine and exocrine function. With a growing body of work that directly shapes clinical practice, Dr. Engelsman is at the forefront of integrating robotic precision into endocrine oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4